<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DC58F2F8-89B4-4E47-9A06-AD1B32620405"><gtr:id>DC58F2F8-89B4-4E47-9A06-AD1B32620405</gtr:id><gtr:name>Texas Technical University</gtr:name><gtr:address><gtr:line1>3601 4th Street</gtr:line1><gtr:line2>Lubbock</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BA2E6ECF-96CF-4B74-8793-41757BEC56FC"><gtr:id>BA2E6ECF-96CF-4B74-8793-41757BEC56FC</gtr:id><gtr:name>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/FBB6E497-0DFD-470D-BF56-94DC9E8B68FD"><gtr:id>FBB6E497-0DFD-470D-BF56-94DC9E8B68FD</gtr:id><gtr:name>Philipps University of Marburg</gtr:name><gtr:address><gtr:line1>Phillips Universtaet Marburg</gtr:line1><gtr:line2>Beigenstrasse 10</gtr:line2><gtr:line4>Marburg</gtr:line4><gtr:postCode>D-35032</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/52D1C081-EC79-45E6-A6A5-939EB33DF774"><gtr:id>52D1C081-EC79-45E6-A6A5-939EB33DF774</gtr:id><gtr:name>Brescia University Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/581E0F16-A0E6-4EE1-9CC3-A5DCE995756E"><gtr:id>581E0F16-A0E6-4EE1-9CC3-A5DCE995756E</gtr:id><gtr:name>University of Zagreb</gtr:name><gtr:address><gtr:line1>Trg marsala Tita 14</gtr:line1><gtr:postCode>10000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:department>Institute of Neurology</gtr:department><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/340288BD-BCA1-46AA-BA5C-D85DDA0D29C8"><gtr:id>340288BD-BCA1-46AA-BA5C-D85DDA0D29C8</gtr:id><gtr:name>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0975468D-C7A0-4AD1-99E9-AC18841FBAF3"><gtr:id>0975468D-C7A0-4AD1-99E9-AC18841FBAF3</gtr:id><gtr:name>Justus-Liebig University Giessen</gtr:name><gtr:address><gtr:line1>Justus-Liebig Universitat Giessen</gtr:line1><gtr:line2>Ludwigstrasse 23</gtr:line2><gtr:line4>Giessen</gtr:line4><gtr:postCode>D-35390</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2448D059-1C4B-4E76-A4C6-8A3109B8F194"><gtr:id>2448D059-1C4B-4E76-A4C6-8A3109B8F194</gtr:id><gtr:name>University of Gothenburg</gtr:name><gtr:address><gtr:line1>University of Gothenburg</gtr:line1><gtr:line2>PO Box 100</gtr:line2><gtr:line4>Gothenburg</gtr:line4><gtr:line5>SE 405 30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6711BFCB-ACD5-4149-9C97-283269DF2778"><gtr:id>6711BFCB-ACD5-4149-9C97-283269DF2778</gtr:id><gtr:name>Mayo Clinic</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3CFB9490-9508-4E43-A019-042327F992A7"><gtr:id>3CFB9490-9508-4E43-A019-042327F992A7</gtr:id><gtr:name>Eisai Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/91427003-DFB6-48F9-848A-32A456E1C00F"><gtr:id>91427003-DFB6-48F9-848A-32A456E1C00F</gtr:id><gtr:name>Royal Free Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/743B0403-114A-4062-A04B-26B6E57DE502"><gtr:id>743B0403-114A-4062-A04B-26B6E57DE502</gtr:id><gtr:name>Columbia University</gtr:name><gtr:address><gtr:line1>Columbia University</gtr:line1><gtr:line2>2960 Broadway</gtr:line2><gtr:line4>New York</gtr:line4><gtr:line5>NY 10027-6902</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/89D5574C-AAF7-4D96-832C-C2BA623123CE"><gtr:id>89D5574C-AAF7-4D96-832C-C2BA623123CE</gtr:id><gtr:name>Eberhard Karls University Tuebingen</gtr:name><gtr:address><gtr:line1>Wilhelmstra?e 7</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DC58F2F8-89B4-4E47-9A06-AD1B32620405"><gtr:id>DC58F2F8-89B4-4E47-9A06-AD1B32620405</gtr:id><gtr:name>Texas Technical University</gtr:name><gtr:address><gtr:line1>3601 4th Street</gtr:line1><gtr:line2>Lubbock</gtr:line2><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BA2E6ECF-96CF-4B74-8793-41757BEC56FC"><gtr:id>BA2E6ECF-96CF-4B74-8793-41757BEC56FC</gtr:id><gtr:name>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0AEFDD04-383A-4977-9F05-440376448760"><gtr:id>0AEFDD04-383A-4977-9F05-440376448760</gtr:id><gtr:name>International Centre for Genetic Engineering and Biotechnology</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/8218E276-85FA-4CD5-86AA-232A830B5037"><gtr:id>8218E276-85FA-4CD5-86AA-232A830B5037</gtr:id><gtr:name>University of Texas at San Antonio</gtr:name><gtr:address><gtr:line1>One UTSA Circle</gtr:line1><gtr:line4>San Antonio</gtr:line4><gtr:line5>TX 78249-1644</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0407B94D-DABF-4B46-B5F0-2CBDC1C63C67"><gtr:id>0407B94D-DABF-4B46-B5F0-2CBDC1C63C67</gtr:id><gtr:name>national Institute on Aging</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/314A3F92-9F78-4782-891F-990F9E739DC4"><gtr:id>314A3F92-9F78-4782-891F-990F9E739DC4</gtr:id><gtr:name>Medical University of Vienna</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/FBB6E497-0DFD-470D-BF56-94DC9E8B68FD"><gtr:id>FBB6E497-0DFD-470D-BF56-94DC9E8B68FD</gtr:id><gtr:name>Philipps University of Marburg</gtr:name><gtr:address><gtr:line1>Phillips Universtaet Marburg</gtr:line1><gtr:line2>Beigenstrasse 10</gtr:line2><gtr:line4>Marburg</gtr:line4><gtr:postCode>D-35032</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DD21B8FC-26A6-4A3A-9A23-207B6667CB41"><gtr:id>DD21B8FC-26A6-4A3A-9A23-207B6667CB41</gtr:id><gtr:name>University of Pittsburgh</gtr:name><gtr:address><gtr:line1>University of Pittsburgh</gtr:line1><gtr:line4>Pittsburgh</gtr:line4><gtr:line5>Pennsylvania</gtr:line5><gtr:postCode>PA 15260</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/487043E2-21FC-4052-A0CA-AB404DE87BA4"><gtr:id>487043E2-21FC-4052-A0CA-AB404DE87BA4</gtr:id><gtr:name>Children's Hospital of Philadelphia</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/52D1C081-EC79-45E6-A6A5-939EB33DF774"><gtr:id>52D1C081-EC79-45E6-A6A5-939EB33DF774</gtr:id><gtr:name>Brescia University Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/581E0F16-A0E6-4EE1-9CC3-A5DCE995756E"><gtr:id>581E0F16-A0E6-4EE1-9CC3-A5DCE995756E</gtr:id><gtr:name>University of Zagreb</gtr:name><gtr:address><gtr:line1>Trg marsala Tita 14</gtr:line1><gtr:postCode>10000</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/D2810C82-B896-4F77-91EA-BA0FD557D2AA"><gtr:id>D2810C82-B896-4F77-91EA-BA0FD557D2AA</gtr:id><gtr:firstName>Rohan</gtr:firstName><gtr:surname>de Silva</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501560"><gtr:id>36361724-2D3B-4E4F-84CF-4CA7A94281D9</gtr:id><gtr:title>Investigation of the pathogenic basis of the tau gene association with neurodegeneration</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501560</gtr:grantReference><gtr:abstractText>The tau protein is an indispensable building block of a healthy nerve cell. Its main function is in the scaffolding network that supports the axons, the long, delicate processes that extend from the nerve cells. A healthy nerve cell requires a finely regulated supply of tau protein. It is now recognised that subtle variations within the tau gene and protein contribute to some movement disorders and dementias such as progressive supranuclear palsy (PSP) and Alzheimer s disease (AD). In recent work, we have used complex genetic analysis to pinpoint which regions of the tau gene contain such variations. We also have shown that their malign influence is by way of increasing production of the tau protein. With this project, we are using cellular and genetic models to investigate exactly how, within the context of the nerve cell, these genetic variations lead to the increased production of the tau protein. A better understanding of this could contribute towards the development of therapeutic approaches that, with greater precision, target the defective pathways. In the case of the tau gene, this could be by fine adjustment of tau protein production to the precise levels that a healthy nerve cell requires.</gtr:abstractText><gtr:technicalSummary>Tauopathies are the class of neurodegenerative disorders characterised by pathological inclusions containing fibrillar deposits of the microtubule-associated protein, tau. The tau gene (MAPT) is mutated in frontotemporal dementia with parkinsonism with tau pathology linked to chromosome 17 (FTDP-17T) and, though not mutated, the H1 haplotype of MAPT is highly associated with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) and, to a lesser extent, with sporadic Parkinson?s disease (PD). We have succeeded in describing the full extent of the MAPT haplotype to a region of near complete linkage disequilibrium (LD) extending over about 1.8 million base pairs and have identified sub-haplotypes within this region, particularly in MAPT itself and MAPT promoter polymorphisms affecting the core promoter and putative conserved enhancer domains that are more associated with PSP, CBD and Alzheiimer s disease (AD). Furthermore, recent findings show that the extended LD of the MAPT region is caused by a large genomic inversion and this region is subject to further chromosomal rearrangements including deletions and multiplications. In this work, we propose a systematic approach to study the potential effects of the MAPT gene polymorphisms and the gross genomic rearrangements on the expression and splicing of MAPT and genes in flanking regions. We will map the inverted chromosomal region in order to identify any disease-specific, pathogenic configurations, including partial and complete deletion or multiplication of genes.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>854584</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Perelman School of Medicine</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>39E2CF33-7C69-446E-8855-AF8B27AE217A</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-3</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Tau in Parkinson's disease</gtr:description><gtr:id>7CB81BEA-C92F-458F-AD57-C6DB6CDEE811</gtr:id><gtr:impact>18162161, 23408064, 21738488
Multidisciplinary: Genetics, Clinical</gtr:impact><gtr:outcomeId>708A9EB0317-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Screened tagging SNPs for tau gene region in sporadic Parkinson's disease cases.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute for Women's Health</gtr:department><gtr:description>Simon-Raj In vivo work</gtr:description><gtr:id>84CE0B60-A705-47C7-9F61-BEB2D8F81992</gtr:id><gtr:impact>No outputs - in progress</gtr:impact><gtr:outcomeId>5889f52add6066.00682686-1</gtr:outcomeId><gtr:partnerContribution>Maintenance of mouse colony, AAV injection and behavioural studies</gtr:partnerContribution><gtr:piContribution>Indentification and characterisation of tau gene promoter associated long-non-coding RNA gene involved in regulation of tau gene. Design of active minimised variants and derivation of AAV expression vectors for in vivo work</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mayo Clinic</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>F301D467-EB30-47E7-A164-25105771A9F9</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-2</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Columbia University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Biomedical Engineering</gtr:department><gtr:description>WUSTL CRISPR</gtr:description><gtr:id>1472A002-6559-439B-85D0-A4CC656069EC</gtr:id><gtr:impact>In progress</gtr:impact><gtr:outcomeId>5889f0d4bafd68.29789372-1</gtr:outcomeId><gtr:partnerContribution>Partners are helping us gene edit by CRISPR the tau gene promoter polymorphisms and deactivation of the essential elements of the non-coding RNA gene to confirm functionality</gtr:partnerContribution><gtr:piContribution>We identified crucial polymprphisms in the tau gene promoter and a non-coding RNA gene overlapping with the tau gene promoter that regulates expression, including identification of the essential elements of the non-coding RNA gene.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Mammalian Genetics Unit</gtr:department><gtr:description>TDP43 and tau expression</gtr:description><gtr:id>DD2DDA06-3434-40C3-9C56-C7301A2F4319</gtr:id><gtr:impact>In collaboration we have shown that TDP43 has a key effect on the regulation of tau gene expression.</gtr:impact><gtr:outcomeId>YvHYX2cHdtC-2</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contribution and access to research reagents developed by groupExchange of research reagents and tools</gtr:partnerContribution><gtr:piContribution>We initiated the project and are responsible for planning and carrying out the bulk of the work.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Children's Hospital of Philadelphia</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Center for Applied Genomics</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>6F7901D5-1266-49AF-8D6E-1FD60A66B645</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-5</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Zagreb</gtr:collaboratingOrganisation><gtr:country>Croatia, Republic of</gtr:country><gtr:department>Croatian Institute for Brain Research</gtr:department><gtr:description>Neuropathology and genetics of tauopathies</gtr:description><gtr:id>F9C10E05-F3D6-4E9C-8D51-22CF1FC90BB1</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>fXrCG7nCGX8-1</gtr:outcomeId><gtr:partnerContribution>Provided and classified local postmortem patient material</gtr:partnerContribution><gtr:piContribution>Screening tau gene haplotypes of clinical dementia cases and contributed tau isoform-specific antibodies and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Tau locus deletions and developmental delay</gtr:description><gtr:id>C5700E8A-870E-400B-9189-46C62080C596</gtr:id><gtr:impact>16906163
Multidisciplinary: Clinical, Genetics</gtr:impact><gtr:outcomeId>38BEE56547E-1</gtr:outcomeId><gtr:partnerContribution>Provided patient material and initial data</gtr:partnerContribution><gtr:piContribution>Mapped MAPT gene region for large deletion that causes developmental delay and facial dysmorphia in young children</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>August Pi i Sunyer Biomedical Research Institute (IDIBAPS)</gtr:collaboratingOrganisation><gtr:country>Spain, Kingdom of</gtr:country><gtr:department>Hospital Clinic of Barcelona</gtr:department><gtr:description>Tau genetics and pathology in PD with dementia</gtr:description><gtr:id>81CE53D4-D43C-4A8E-89E6-DFD6D84E87D5</gtr:id><gtr:impact>21596773
Neuropathological correlates to PD with and without dementia established
Published in Brain</gtr:impact><gtr:outcomeId>Z1NtmnkSuGT-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contribution</gtr:partnerContribution><gtr:piContribution>Collaborator was the primary person involved in the project and collated/analysed clinical, pathological and genetic data for PD cases at the Queen Square Brain Bank, London</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>International Centre for Genetic Engineering and Biotechnology</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>TDP43 and tau expression</gtr:description><gtr:id>4C9326EF-9BF9-4D69-916A-F54E7B59844D</gtr:id><gtr:impact>In collaboration we have shown that TDP43 has a key effect on the regulation of tau gene expression.</gtr:impact><gtr:outcomeId>YvHYX2cHdtC-3</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contribution and access to research reagents developed by groupExchange of research reagents and tools</gtr:partnerContribution><gtr:piContribution>We initiated the project and are responsible for planning and carrying out the bulk of the work.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Gothenburg</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Tau-based diagnostic biomarkers in CSF</gtr:description><gtr:id>03195890-3764-47E7-93E0-9A041EAB72EF</gtr:id><gtr:impact>22862741
 Clinical, biochemistry, clinical diagnostics</gtr:impact><gtr:outcomeId>mdwiFngmoqN-1</gtr:outcomeId><gtr:partnerContribution>Contributed patient CSF samples and intellectual input</gtr:partnerContribution><gtr:piContribution>Developed sensitive assays for detection of tau variants as biomarkers in CSF in neurodegenerative disorders</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Study of MAPT in PSP</gtr:description><gtr:id>93779826-5828-4CAB-8F68-EB2152CF0040</gtr:id><gtr:impact>16493238 17174556 
Multidisciplinary: Clinical, Genetics, Cell Biology, Neuropathology</gtr:impact><gtr:outcomeId>85442865C2A-1</gtr:outcomeId><gtr:partnerContribution>Use of high-throughput genotyping technology and intellectual contributions to successful projects</gtr:partnerContribution><gtr:piContribution>Mapped MAPT gene in PSP and established in vitro luciferase assay for allele-specific gene expression studies.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Identification of genetic cause of frontotemporal dementia in a population isolate</gtr:description><gtr:id>6F82B09D-0BB2-47EA-A18C-5C6DE097646D</gtr:id><gtr:impact>Genomewide screening completed. Analysis in progress
Poster presented at SINDEM meeting in Florence, Italy, 2010. Analysis of exome data pending</gtr:impact><gtr:outcomeId>kBTKDzNqkb1-2</gtr:outcomeId><gtr:partnerContribution>DNA samples from affected cases. Clinical classificationThey have contributed key bioinformatics expertise</gtr:partnerContribution><gtr:piContribution>Genomewide autozygosity analysis to identify any regions of homozygosity. Exome sequencing of affected individuals</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Justus Liebig University Giessen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Institute of Human Genetics</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>2ED6D71F-D0BB-403F-9B5A-7637A2CB3B24</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-6</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Prion Unit</gtr:department><gtr:description>Tau mutation screening in tauopathy cases</gtr:description><gtr:id>855D2D82-2188-42A5-A6CE-4F2B1DA4D114</gtr:id><gtr:impact>19884572, 20838030, 23998997, 22595371
Multidisciplinary: Clinical, Genetics, Biochemistry, Neuropathology</gtr:impact><gtr:outcomeId>A1DAB101A4C-2</gtr:outcomeId><gtr:partnerContribution>Provided clinical patient samples and clinical data</gtr:partnerContribution><gtr:piContribution>Sequenced tauopathy cases and identified causative mutations.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Brescia University Hospital</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:department>Neurology Clinic</gtr:department><gtr:description>Identification of genetic cause of frontotemporal dementia in a population isolate</gtr:description><gtr:id>A55D8998-6348-4088-B926-042782C48D66</gtr:id><gtr:impact>Genomewide screening completed. Analysis in progress
Poster presented at SINDEM meeting in Florence, Italy, 2010. Analysis of exome data pending</gtr:impact><gtr:outcomeId>kBTKDzNqkb1-1</gtr:outcomeId><gtr:partnerContribution>DNA samples from affected cases. Clinical classificationThey have contributed key bioinformatics expertise</gtr:partnerContribution><gtr:piContribution>Genomewide autozygosity analysis to identify any regions of homozygosity. Exome sequencing of affected individuals</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Philipp University of Marburg</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Department of Neurology</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>52FB086F-99F3-458E-A278-93FE2141F3E3</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-1</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Free Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>A cell model for exosomal release of tau</gtr:description><gtr:id>DB96AC46-7943-4284-B102-C4EBEAD8F6D8</gtr:id><gtr:impact>Early stage in research but we have secured a studentship from Alzheimer's Society UK.</gtr:impact><gtr:outcomeId>54648c8cb24b43.22753310-1</gtr:outcomeId><gtr:partnerContribution>They are carrying out the laboratory investigations of the cell lines and have also secured the PhD studentship starting in Spring 2015.</gtr:partnerContribution><gtr:piContribution>I have provided tau cell lines and tau antibodies that will form the core of this project to investigate chaperone mediated autophagy exosomal release of tau as well as intellectual input and co-supervision of PhD student</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Texas</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Mitchell Centre for Neurodegenerative Diseases</gtr:department><gtr:description>Tau oligomers in neurodegeneration</gtr:description><gtr:id>1CB92147-5C78-45D5-9CDE-B2246B6CDB7C</gtr:id><gtr:impact>Ongoing</gtr:impact><gtr:outcomeId>s3rW18dEco3-1</gtr:outcomeId><gtr:partnerContribution>Provided oligomer-specific antibodies and assaying oligomer levels in patient CSF samples</gtr:partnerContribution><gtr:piContribution>Provided patient samples and am assessing tau-oligomer specific antibodies from partner on brain tissue. Studying release and intercellular spread of tau oligomer species.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Tau mutation screening in tauopathy cases</gtr:description><gtr:id>B14979A4-42ED-4295-AB0B-967DA03A1BC9</gtr:id><gtr:impact>19884572, 20838030, 23998997, 22595371
Multidisciplinary: Clinical, Genetics, Biochemistry, Neuropathology</gtr:impact><gtr:outcomeId>A1DAB101A4C-1</gtr:outcomeId><gtr:partnerContribution>Provided clinical patient samples and clinical data</gtr:partnerContribution><gtr:piContribution>Sequenced tauopathy cases and identified causative mutations.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:department>Center for Molecular Medicine</gtr:department><gtr:description>Tau-based gene therapy for neurodegenerative disorders</gtr:description><gtr:id>41BCC546-00D5-45E8-B1C8-860F66BBDA8C</gtr:id><gtr:impact>None to date - still in progress</gtr:impact><gtr:outcomeId>Zv8pmq51pNx-1</gtr:outcomeId><gtr:partnerContribution>Injection and study of mouse models for tauopathy</gtr:partnerContribution><gtr:piContribution>We have developed vectors to test the concept of gene therapy directed at tau gene expression in slowing or halting the progress of tau-relaed neurodegeneration.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eberhard Karls University of Tubingen</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Centre of Neurology and Hertie-Institute for Clinical Brain Research</gtr:department><gtr:description>CSF biomarkers for differential diagnosis of PSP clinical sub-types</gtr:description><gtr:id>CF3AE351-1BC0-488F-8E38-1B762FDE158D</gtr:id><gtr:impact>None yet</gtr:impact><gtr:outcomeId>ieade9fdSra-1</gtr:outcomeId><gtr:partnerContribution>Patient samples and intellectual contribution</gtr:partnerContribution><gtr:piContribution>Developed sensitive assays for quantitation of tau variants in CSF</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>MAPT in PSP clinical sub-types</gtr:description><gtr:id>FEA4F1B8-95D3-48EF-ADD9-8F203D15724A</gtr:id><gtr:impact>17274033 17525140 23432126
Multidisciplinary: Clinical, Genetics, Neuropathology, Biochemistry</gtr:impact><gtr:outcomeId>7490FEA084B-1</gtr:outcomeId><gtr:partnerContribution>Contributed patient clinical, neuropathological and biochemical data</gtr:partnerContribution><gtr:piContribution>Analysed genetic association of tau gene haplotypes in PSP clinical sub-types, including Richardson's Syndrome, PSP-parkinsonism.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute on Aging</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Tau mutation screening in tauopathy</gtr:description><gtr:id>4B87996D-DAE6-482F-8168-DA849A4E0380</gtr:id><gtr:impact>17723255
Multidisciplinary: Clinical, Genetics, Biochemistry, Neuropathology</gtr:impact><gtr:outcomeId>9AB2046D0A9-1</gtr:outcomeId><gtr:partnerContribution>Contributed patient DNA and brain sample and clinical data.Exchanged patient samples, carrying out candidate gene sequencing, exchange of lab personnel.</gtr:partnerContribution><gtr:piContribution>Sequenced tau gene and identified tau gene deletion - investigated effect of deletion on tau gene splicing</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Eisai Ltd</gtr:collaboratingOrganisation><gtr:country>Japan</gtr:country><gtr:description>Tau-based therapies in tauopathies</gtr:description><gtr:id>483F8C66-31B7-4375-B64A-A9A29C009F5D</gtr:id><gtr:impact>We have developed cell-based system for quantification of tau aggregation and anti-aggregation properties of new antibodies. We have also developed TWELVE new antibodies that are currently being subject to testing and, ultimately, target validation.</gtr:impact><gtr:outcomeId>TQ9CmaihWC2-1</gtr:outcomeId><gtr:partnerContribution>Facilitating collaboration by testing antibodies and proposing ways of improving antibody affinity. Ongoing collaboration as part of UCL-Eisai Therapeutic Innovation Group (TIG) in developing new, more effective antibodies for tau-targeted passive immunotherapy</gtr:partnerContribution><gtr:piContribution>Based on our research findings and reagents developed, I proposed a collaboration to develop a passive immunotherapy for tauopathies and small molecule screening for regulating tau gene expression. I have provided relevant antibodies and a cell culture model for high-throughput screening. I meet regularly with partners at Eisai in planning meetings and provide intellectual input</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical University of Vienna</gtr:collaboratingOrganisation><gtr:country>Austria, Republic of</gtr:country><gtr:description>Tau mutation screening</gtr:description><gtr:id>13D2283D-3395-4C9C-A647-EF61690AF58A</gtr:id><gtr:impact>18066559
Multidisciplinary: Clinical, Genetics, Biochemistry, Neuropathology</gtr:impact><gtr:outcomeId>CC73739D0E8-1</gtr:outcomeId><gtr:partnerContribution>Contributed patient DNA and brain samples as well as clinical description</gtr:partnerContribution><gtr:piContribution>Sequenced patient DNA for tau mutations and carried out splicing study and protein analysis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pittsburgh</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Pittsburgh</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>C01B00CA-0153-4840-AF46-5A51CE0A5C23</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-4</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cardiff University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Medicine</gtr:department><gtr:description>Regional expression QTLs of tau in human brain</gtr:description><gtr:id>6BF24485-C626-458F-BD28-57CD42589D16</gtr:id><gtr:impact>23428180
Multidisciplinary: Clinical, Genetic, biochemistry</gtr:impact><gtr:outcomeId>sGCZSMP58Rc-1</gtr:outcomeId><gtr:partnerContribution>Did bulk of analysis</gtr:partnerContribution><gtr:piContribution>Contributed and prepared patient postmortem samples and carried out some of the gene expression analysis and intellectual input</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Clinical and Experimental Epilepsy</gtr:department><gtr:description>Stephanie-Seizures</gtr:description><gtr:id>0B10BAD7-AAD3-4F13-A702-6FC5941E9467</gtr:id><gtr:impact>In progress - no outcomes</gtr:impact><gtr:outcomeId>5889f6506d6128.91051171-1</gtr:outcomeId><gtr:partnerContribution>Maintenance of mouse colony. Assessment of experimentally induced epileptic seizures and affect of tau reduction due to injection of AAV vectors.</gtr:partnerContribution><gtr:piContribution>Identification and characterisation of long non-coding RNA gene linked to the tau gene that is involved in regulation of tau gene expression. Characterised functional domains and derived truncated active variant. Raised AAV vectors for expression of variants in vivo</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>TDP43 and tau expression</gtr:description><gtr:id>1FD8E169-4484-4D27-BFBD-5E03751C2A28</gtr:id><gtr:impact>In collaboration we have shown that TDP43 has a key effect on the regulation of tau gene expression.</gtr:impact><gtr:outcomeId>YvHYX2cHdtC-1</gtr:outcomeId><gtr:partnerContribution>Intellectual contributionIntellectual contribution and access to research reagents developed by groupExchange of research reagents and tools</gtr:partnerContribution><gtr:piContribution>We initiated the project and are responsible for planning and carrying out the bulk of the work.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Peebler Foundation PSP Genetics Programme</gtr:department><gtr:description>PSP Genomewide Association Study Consortium</gtr:description><gtr:id>A510ED57-E40E-45CF-A8F4-EE838A18C0DF</gtr:id><gtr:impact>21685912, 24252572
Genomewide screening and analysis completed with the identification of multiple genes that are genomewide significant. Novel pathways implicated in PSP pathogenesis. 
Results presented at ICAD, Honolulu, 2010 and International PSP Workshop, San Diego, 2010.
Work published in Nature Genetics.</gtr:impact><gtr:outcomeId>TV26GbhBwuu-7</gtr:outcomeId><gtr:partnerContribution>Patient samplesIntellectual, sample and clinical contributionConsortium leader, sample and intellectual contribution, microarray and data analysisData Analysis, Intellectual contributionData analysis and intellectual contributionSample contribution, intellectual contributionFunded and coordinated consortium</gtr:partnerContribution><gtr:piContribution>Contributed pathologically confirmed and clinical cases for genomewide analysis. Founder member of core steering group in consortium.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Texas Tech University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Internal Medicine</gtr:department><gtr:description>Tau mutation screening in tauopathy</gtr:description><gtr:id>28E411C8-4A48-40E7-AFC7-FAF47994E6A4</gtr:id><gtr:impact>17723255
Multidisciplinary: Clinical, Genetics, Biochemistry, Neuropathology</gtr:impact><gtr:outcomeId>9AB2046D0A9-2</gtr:outcomeId><gtr:partnerContribution>Contributed patient DNA and brain sample and clinical data.Exchanged patient samples, carrying out candidate gene sequencing, exchange of lab personnel.</gtr:partnerContribution><gtr:piContribution>Sequenced tau gene and identified tau gene deletion - investigated effect of deletion on tau gene splicing</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Symposium for Carers and Therapists</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A9F1E461-674D-4D0F-B30C-B0E03D50F382</gtr:id><gtr:impact>Gave lay research update to patients and carers in the form of a seminar.

Caused greater interest in genetic impact of PSP</gtr:impact><gtr:outcomeId>B6D8FC5FC7B</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>London Support Group - PSP Association</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>62C383D5-7B2D-495C-84FC-C6D3DBDF2611</gtr:id><gtr:impact>Research lay update to local patient/carer support group

Conveyed latest research findings and described prospect of treatments</gtr:impact><gtr:outcomeId>60C62B77F07</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Brain Bank Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>63D4AA00-FE18-4BE5-AC0B-62870230BC47</gtr:id><gtr:impact>Wrote lay article for Queen Sq Brain Bank Newsletter that was distributed among patient groups, families, carers and medical practitioners.</gtr:impact><gtr:outcomeId>5889f8d522d205.51815760</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Queen Sq Brain Bank brochure</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DAD69BF5-5D9D-4A6E-9D79-895C6658F74E</gtr:id><gtr:impact>Magazine for charity (PSP Association) with my articles in layspeak was distributed to patients and interest groups

Greater awareness of charity funded research</gtr:impact><gtr:outcomeId>Sz3BZHBii3R</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research for Later Life Conference</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7C55B61E-736D-447C-9D8A-35CF4476771D</gtr:id><gtr:impact>Attended by a mix of researchers and age welfare interest groups - role of tau in neurodegeneration and potential for therapies discussed

n/a</gtr:impact><gtr:outcomeId>B6YPvRFUryq</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>PSP Association Newsletter</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>D9782869-D0AA-4DEB-A96D-78687E819EC8</gtr:id><gtr:impact>Contributed lay research updates to quarterly &amp;quot;PSP Matters&amp;quot; magazine published by the PSP Association

Better awareness</gtr:impact><gtr:outcomeId>12B86E684BC</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Research Update PSP Association Trustees</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>120B724F-EA86-4217-A1FC-5BC53E5FA1A6</gtr:id><gtr:impact>Provided lay update on research and successfully made case for further funding for the development of a sensitive assay for quantification of tau in cerebrospinal fluid

Successfully obtained funding for a further year.</gtr:impact><gtr:outcomeId>DA6A3B375AF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Reta Lila Weston Institute Research Report</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D77097A8-5850-440D-80FE-F85EC0C69C17</gtr:id><gtr:impact>Book describing research output of Institute to the lay person. Contributed article on our research

Just published.</gtr:impact><gtr:outcomeId>NJdMdHN9fCd</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2011,2012,2013,2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Age UK brochure entry</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>10845B8C-7CBD-4E38-9BA1-683A0FAB53A7</gtr:id><gtr:impact>Lay summary of my research together with its importance outlined in brochure for distribution to potential donors to Age UK.

Too early to judge impact</gtr:impact><gtr:outcomeId>hRJUdBScV7k</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>75049</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>CurePSP Investigator Initiated Research Grant</gtr:description><gtr:end>2016-07-02</gtr:end><gtr:fundingOrg>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:fundingOrg><gtr:id>75937C74-5551-4FCF-8B27-B87D6EFECCD4</gtr:id><gtr:outcomeId>54648fd2863964.83128926</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>11271</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>International Joint Project</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>The Royal Society</gtr:fundingOrg><gtr:id>114DD9B9-CF90-4F40-B60F-3953E55AE624</gtr:id><gtr:outcomeId>E2072A23EFE0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>172193</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Research Grant</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>CBD Solutions</gtr:fundingOrg><gtr:id>5E81707A-45BD-4A89-A5A9-2503E2A9AB5D</gtr:id><gtr:outcomeId>58ca79b0a0cee6.49852600</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Peacock Trust Research Grant</gtr:description><gtr:end>2011-01-02</gtr:end><gtr:fundingOrg>Peacock Charitable Trust</gtr:fundingOrg><gtr:id>D541A356-0807-491E-8987-C5C85681F4FA</gtr:id><gtr:outcomeId>DC4CB070A7A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>87504</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART PhD Studentship</gtr:description><gtr:end>2010-09-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>7CA15624-9229-47CD-A15B-5517A3BE302E</gtr:id><gtr:outcomeId>7B612C60D9A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>126200</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>The Irene &amp;amp; Abe Pollin Fund for CBD Research</gtr:description><gtr:end>2012-05-02</gtr:end><gtr:fundingOrg>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:fundingOrg><gtr:id>82DB9A04-0316-47AA-A507-7A6AAB74D9EF</gtr:id><gtr:outcomeId>15D6EB3D5360</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>213609</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ART Major Research Grant (Co-applicant)</gtr:description><gtr:end>2011-04-02</gtr:end><gtr:fundingOrg>Alzheimer's Research UK</gtr:fundingOrg><gtr:id>D2562F07-20A6-4DDC-89CF-8CF73CC2DFE8</gtr:id><gtr:outcomeId>9992C0F589B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>12600</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cure PSP/Charles Peebler Foundation Genetics Consortium</gtr:description><gtr:end>2010-01-02</gtr:end><gtr:fundingOrg>Cure PSP (Foundation for PSP/CBD and Related Brain Diseases)</gtr:fundingOrg><gtr:id>999E75C8-DC44-402B-946C-D3D330D8550E</gtr:id><gtr:outcomeId>jtGXuK4ryk90</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34957</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Innovation Grant</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Parkinson's UK</gtr:fundingOrg><gtr:fundingRef>K-1212</gtr:fundingRef><gtr:id>770E0736-7B77-4D51-90AF-7157112A3FA9</gtr:id><gtr:outcomeId>pre6oj9ETBt</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>43180</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PSP Association Research Grant</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Progressive Supranuclear Palsy Association (PSPA)</gtr:fundingOrg><gtr:id>43F1839A-BC98-4271-B5F2-F22D9A40A744</gtr:id><gtr:outcomeId>546491a184bd23.25666146</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1672000</gtr:amountPounds><gtr:country>Unknown</gtr:country><gtr:currCode>SEK</gtr:currCode><gtr:currCountryCode>Sweden</gtr:currCountryCode><gtr:currLang>sv_SE</gtr:currLang><gtr:description>Collaborative research grant</gtr:description><gtr:end>2018-02-02</gtr:end><gtr:fundingOrg>CBD Solutions</gtr:fundingOrg><gtr:id>2FDA40B5-EE08-42FA-8AB7-D73AC453B2AD</gtr:id><gtr:outcomeId>56e0066db90c95.11114787</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>72000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Research into Ageing Fund (RiAF)</gtr:department><gtr:description>PhD Studentship</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Age UK</gtr:fundingOrg><gtr:id>38CEFA0A-99C9-48CA-9D52-3033B4528929</gtr:id><gtr:outcomeId>CFBC251897B0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>The use of coding-gene linked long-non-coding RNA gene transcripts for transcriptional regulation of gene expression - as a therapeutic or research tool.</gtr:description><gtr:grantRef>G0501560</gtr:grantRef><gtr:id>E8E181A9-4BFC-4D11-8F39-A412F0DCD171</gtr:id><gtr:impact>Collaborations to test concept in vivo and approach by potential investors to for spin out company.</gtr:impact><gtr:licensed>No</gtr:licensed><gtr:outcomeId>5889fb3d6c9a33.72338356</gtr:outcomeId><gtr:patentId>1608907.0</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>MEANS FOR MODULATING GENE EXPRESSION</gtr:title><gtr:yearProtectionGranted>2016</gtr:yearProtectionGranted></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Imbalances in the tau 3R and 4R isoforms are an important cause of many of the common neurological disorders of old age. The two antibodies recognise 3R and 4R tau and are now routinely used in pathological diagnosis of neurological disorders, research studies of animal models of neurological disorders and in biochemistry of neurological disorders.</gtr:description><gtr:grantRef>G0501560</gtr:grantRef><gtr:id>97CE6EF0-E064-455A-B928-AB96CA6718A8</gtr:id><gtr:impact>These antibodies have provided the basis for sandwich ELISA for quantitation of tau isoforms in tissue (PMID: 19427527) and more sensitive immuno-PCR assays for quantitation of tau isoforms in cerebrospinal fluid (PMID: 22862741). Our initial validation study in clinical CSF samples suggest diagnostically relevant differences in tau isoforms in tauopathies.</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>f3AMhEwSi22</gtr:outcomeId><gtr:protection>Protection not required</gtr:protection><gtr:title>Tau isoform-specific monoclonal antibodies</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs><gtr:productOutput><gtr:description>Refined/truncated lncRNA transcript delivery in vivo by AAV vectors to test if tau is reduced and if there is any therapeutic benefits in animal models of tauopathies. Most recent funding from Brain Research Trust.</gtr:description><gtr:id>B4F033C1-0D94-48F3-AB5C-CD033328C49F</gtr:id><gtr:impact>Possibly using the same concept to regulate translation of other genes</gtr:impact><gtr:outcomeId>588b543938b012.83415822</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>lncRNAs and therapeutic reduction of tau</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2016</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>We identified specific RNAs that modulate tau gene expression. We have completed testing in cell models. Current and most recent funding: PDUK</gtr:description><gtr:id>12883255-58E3-4977-8355-1D9E9D02EA52</gtr:id><gtr:impact>Very specific reduction of tau gene expression in cell models. Other work suggests that reduction of tau levels could be an effective therapy in neurodegenerative tauopathies.</gtr:impact><gtr:outcomeId>jtRw64E59i5</gtr:outcomeId><gtr:stage>Refinement.  Non-clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>RNA based therapy</gtr:title><gtr:type>Therapeutic Intervention - Cellular and gene therapies</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Disturbances in tau isoform homeostasis are an important pathogenic mechanism in several progressive neurodegenerative disorders. Based on antibodies that recognise tau isoforms we have developed a sandwich ELISA that enables us to measure these isoforms in human tissue. In addition, we have developed a more sensitive Immuno-PCR assay (IPCR) to quantify tau isoforms in CSF. We have completed measurements of CSF tau isoforms in large collections of clinical CSFs and are currently analysing the data. Most recent funding was from the Brain Research Trust. However this funding is over and we seek further funding as well as collaborations with industry.</gtr:description><gtr:id>987279AF-F43A-4F29-B59D-7E45A8A53A0A</gtr:id><gtr:impact>These are the first assays that enable us to measure tau isoforms in human tissue and CSF. Due to disturbances in the homeostasis of these isoforms causing disease, we believe that these assays could serve as a diagnostic tool and to identify pre-clinical cases. We are currently using the IPCR to measure tau isoforms in a large collection of disease CSFs from various centres in Europe to see if it has any diagnostic value.</gtr:impact><gtr:outcomeId>BAM1qCJmrDN</gtr:outcomeId><gtr:stage>Refinement.  Clinical</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>Assays for CSF tau</gtr:title><gtr:type>Diagnostic Tool - Non-Imaging</gtr:type><gtr:yearDevCompleted>2010</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Genomewide exon array expression data from 10 regions of 100 healthy control brains</gtr:description><gtr:id>325E1352-3D3C-4C4A-AF72-35EF75E3DBFB</gtr:id><gtr:impact>Public availability of data, resource paper (PMID: 25174004) and several publications (internal and external) (please see: http://www.ncbi.nlm.nih.gov/pubmed/?term=ryten+and+weale)</gtr:impact><gtr:outcomeId>54649d86cf0f83.64307461</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>UK Brain Expression Database</gtr:title><gtr:type>Database/Collection of data</gtr:type><gtr:url>http://www.braineac.org</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Bi-cistronic vector allows investigation of CAP- and/or IRES-dependent expression of the tau gene and assess role of non-coding RNA genes and stressors on steering this expression</gtr:description><gtr:id>4AC9CC91-3F19-4096-9FCC-95E77F539116</gtr:id><gtr:impact>As with stable cell lines for non-coding RNA genes, these constructs have allowed us dissect the role of non-coding RNAs in tau gene expression.</gtr:impact><gtr:outcomeId>54b7b549a45f31.24943422</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Bi-cistronic reporter vector for investigation of tau gene promoter activity</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Investigation of the therapeutic potential of reduction of tau protein in CNS using truncated long non-coding RNA linked to the tau gene. Derivation of AAV9 vectors for CNS delivery of the long non-coding RNAs</gtr:description><gtr:id>9C1FD0CD-819E-476B-BD55-320F076139DB</gtr:id><gtr:impact>Project in progress. Expected outcome: Wide CNS distribution after AAV9 injection in mouse model with reduction in brain levels of tau and accompanying therapeutic effect.</gtr:impact><gtr:outcomeId>5889f9e73e1b61.97382204</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>AAV Vectors for CNS expression</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Array-based genomewide expression data from 10 regions of 140 control brains together with genomewide genotype data (UK Brain Expression Consortium)</gtr:description><gtr:id>C3D5FB10-637D-4BBB-847A-BE882E410668</gtr:id><gtr:impact>Publications: 23408064, 23967090, 22723018, 25174004, 24503276</gtr:impact><gtr:outcomeId>B4CoskcrwNz</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Brain expression database</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://ukbec.wordpress.com/</gtr:url><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Genotype data for tau gene in pathologically confirmed PSP cases from the London Queen Square Brain Bank and Mayo Clinic PSP brain bank and appropriate controls.
Genomewide genotype data based on Illumina 660K array for all abovementioned PSP cases.</gtr:description><gtr:id>35868028-824D-4A5F-9BB6-13BD01E34FFA</gtr:id><gtr:impact>Identification of possible functional basis of an association of the tau gene with PSP and CBD.
Identification of other loci genomewide that are associated with PSP implicating novel pathways</gtr:impact><gtr:outcomeId>bKdrJMhWfHK</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>PSP genetic data</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Based on monoclonal antibodies that we developed that recognise the three- and four-repeat isoforms of the tau protein, we have developed ELISA-based platforms for the sensitive measurement of these tau isoforms in brain and CSF. Disturbances in homeostasis of these two isoforms are a central pathogenic mechanism in many of the tauopathies. Early detection of these changes may be important in development of therapies.</gtr:description><gtr:id>15130CAB-6050-4721-B4CD-5AF004E132B1</gtr:id><gtr:impact>The first assays available for measuring brain and CSF tau isoforms.</gtr:impact><gtr:outcomeId>tRNauA3Ft27</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Assays for tau isoform quantitation in brain and CSF</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Clonal neuroblastoma cell lines expressing wild-type and mutant alpha-synuclein and tau isoforms</gtr:description><gtr:id>9ECF3E7A-52CB-4F9A-8C92-9E8BAA04D46D</gtr:id><gtr:impact>Publications (24521289, 22039514 and Marta Swirski, J Scott Miners, Rohan de Silva, Tammaryn Lashley, Helen Ling, Janice Holton, Tamas Revesz and Seth Love (2014) Evaluating the relationship between amyloid-beta and alpha-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease; Alzheimer's Research &amp;amp; Therapy) and successful PhD studentship grant</gtr:impact><gtr:outcomeId>546499234b8397.23585841</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Stably expressing tau and alpha-synuclein cell lines</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>The core promoter and putative conserved enhancer regions of the tau gene promoter have been cloned into a luciferase reporter vector in order to assess the allele-specific differences in promoter polymorphisms that confer disease risk.</gtr:description><gtr:id>657CBF8A-696A-4CDD-B82B-990193B48F41</gtr:id><gtr:impact>We have shown that increased risk of sporadic tauopathies is caused by significantly increased levels of tau gene transcription. This research material could be used for testing approaches to reduce tau transcription as a potential therapy.</gtr:impact><gtr:outcomeId>1C61B53BE9C</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Tau gene allele-specific promoter activity assays in cell culture</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Stable overexpression of non-coding RNA genes enables consistent cell-based model to investigate the downstream regulatory effects of these non-coding genes</gtr:description><gtr:id>9EA85879-BDD5-46E7-B780-057F25BD6AEB</gtr:id><gtr:impact>Have succeeded in clarifying the precise role of the non-coding RNA genes in the post-transcriptional regulation of tau gene expression</gtr:impact><gtr:outcomeId>54b7b47bbed196.66314616</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Stable cell lines for tau gene associated non-coding RNA genes</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>6ECF690E-7AF5-4873-BDAC-7B30C216BB09</gtr:id><gtr:title>An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R- and 4R-specific tau monoclonal antibodies.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d26a3febd09809a570547ffa12ae5ea"><gtr:id>5d26a3febd09809a570547ffa12ae5ea</gtr:id><gtr:otherNames>de Silva R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>1C17A9F1030</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D46612A1-6C7A-401B-87AD-8C7B81CD8FE2</gtr:id><gtr:title>Mesial temporal astrocyte tau pathology in the MRC-CFAS ageing brain cohort.</gtr:title><gtr:parentPublicationTitle>Dementia and geriatric cognitive disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af01bcaabff4dfd4ac18896c34ef80bc"><gtr:id>af01bcaabff4dfd4ac18896c34ef80bc</gtr:id><gtr:otherNames>Lace G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1420-8008</gtr:issn><gtr:outcomeId>pm_14043_23_22868294</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3CF12B54-52BD-4FEA-A6A0-9F790F502332</gtr:id><gtr:title>Analysis of C9orf72 repeat expansions in a large series of clinically and pathologically diagnosed cases with atypical parkinsonism.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3ff2cda0ff39441e9d379b03cb269851"><gtr:id>3ff2cda0ff39441e9d379b03cb269851</gtr:id><gtr:otherNames>Schottlaender LV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>546095478293d9.88279945</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17F42EC5-F2D1-4321-8FD2-9B7F49FF9878</gtr:id><gtr:title>Tau-positive grains are constant in centenarians' hippocampus.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5d26e17d2120078547dd5cee20e4848"><gtr:id>e5d26e17d2120078547dd5cee20e4848</gtr:id><gtr:otherNames>Pham CT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>73487A5CD9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CB204464-F1C8-4777-AD66-BAC4A2C9AA3A</gtr:id><gtr:title>Immunohistochemical investigation of neurofibrillary tangles and their tau isoforms in brains of limbic neurofibrillary tangle dementia.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e47a35c8d70d465cd4aed57c94b8cebe"><gtr:id>e47a35c8d70d465cd4aed57c94b8cebe</gtr:id><gtr:otherNames>Iseki E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>EF00B447450</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3D8426F-AFBD-42F6-BF67-7F036A777F29</gtr:id><gtr:title>Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737a3b1b4bbcc2863da782c70d702de5"><gtr:id>737a3b1b4bbcc2863da782c70d702de5</gtr:id><gtr:otherNames>Vandrovcova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>3C2204D9EFB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DC5CAC13-C6B4-4BEF-BF2A-FB718CBF7FBB</gtr:id><gtr:title>The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/697536feebefd233256c0907479ff552"><gtr:id>697536feebefd233256c0907479ff552</gtr:id><gtr:otherNames>Kara E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14043_23_22595371</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>45AC5CE7-BE22-4667-9CF2-C4566AED1F33</gtr:id><gtr:title>Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e92699e66f262cd182ee6581ab96aae"><gtr:id>5e92699e66f262cd182ee6581ab96aae</gtr:id><gtr:otherNames>H?glinger GU</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>HuAAJcaUc33</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FC54DE68-3C9A-4658-B2CA-A2B596E436F5</gtr:id><gtr:title>Adapting the Sniffin' Sticks to diagnose Parkinson's disease in Sri Lanka.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>E9D9364D46F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E5687D1-BB00-4FFF-85FC-F2400B9168FE</gtr:id><gtr:title>Genetics of progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Handbook of clinical neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59eee19a2cfbf0e9ad3bd8586d222ca4"><gtr:id>59eee19a2cfbf0e9ad3bd8586d222ca4</gtr:id><gtr:otherNames>Pittman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0072-9752</gtr:issn><gtr:outcomeId>pm_14043_13_18631770</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAF975AF-7194-4904-BAB8-451B76D80BA5</gtr:id><gtr:title>Validation of next-generation sequencing technologies in genetic diagnosis of dementia.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/72f7fb44cb0e9d3dbae03fa9e859951a"><gtr:id>72f7fb44cb0e9d3dbae03fa9e859951a</gtr:id><gtr:otherNames>Beck J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14043_23_23998997</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B76AE98C-9734-4542-A14D-BAA5EC2C95B7</gtr:id><gtr:title>Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>eXMpsDYySd3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5751368B-C18D-4D11-AEFA-5B613A9DB6B4</gtr:id><gtr:title>Fine-mapping, gene expression and splicing analysis of the disease associated LRRK2 locus.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14043_23_23967090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A222321-573B-4EFA-8CD8-29FB15A06415</gtr:id><gtr:title>Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/87ec7393654b623810f573566dd2211d"><gtr:id>87ec7393654b623810f573566dd2211d</gtr:id><gtr:otherNames>Shaw-Smith C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>49A36493EFF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B81D789-91DA-43FA-B5EF-9EEF41F30A1B</gtr:id><gtr:title>Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.</gtr:title><gtr:parentPublicationTitle>Biomolecules</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d9454f73ea5dddeab610669e0edffb"><gtr:id>d3d9454f73ea5dddeab610669e0edffb</gtr:id><gtr:otherNames>?imic G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2218-273X</gtr:issn><gtr:outcomeId>5695074046f501.82461034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1CB637B5-5AE5-48D3-96A6-69732961AAF2</gtr:id><gtr:title>Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/699401602f933276abda64770fc6df19"><gtr:id>699401602f933276abda64770fc6df19</gtr:id><gtr:otherNames>Ahmed Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>Q66QTncgf37</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16B80DA9-0811-4B73-B665-C91A55410654</gtr:id><gtr:title>Concomitant progressive supranuclear palsy and multiple system atrophy: more than a simple twist of fate?</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/961fb7c7b58bf324f312f76fae2f3a64"><gtr:id>961fb7c7b58bf324f312f76fae2f3a64</gtr:id><gtr:otherNames>Silveira-Moriyama L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>CF9C0B67C06</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12A9F674-362D-4D8D-9136-FAAD973441FA</gtr:id><gtr:title>Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79c943d719ca6749410f754081f54667"><gtr:id>79c943d719ca6749410f754081f54667</gtr:id><gtr:otherNames>Ling H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>pm_14043_23_23432126</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9508CA37-1809-4CDC-ABD7-239169F85944</gtr:id><gtr:title>Brain tau isoform mRNA and protein correlation in PSP brain</gtr:title><gtr:parentPublicationTitle>Translational Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/12c709bd9c3fa94592eba9c77aae5f6e"><gtr:id>12c709bd9c3fa94592eba9c77aae5f6e</gtr:id><gtr:otherNames>Connie L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>ZkuiiYgaW4h</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>361B8BAB-AF01-4A61-AC5B-C91BB5C35D46</gtr:id><gtr:title>DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a129ffd0554635defe92554b9ccfbb8f"><gtr:id>a129ffd0554635defe92554b9ccfbb8f</gtr:id><gtr:otherNames>Kumaran R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>0705139624B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B07B7D16-0F3D-414C-ACC5-19EBD68158A2</gtr:id><gtr:title>Monoaminergic neuropathology in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Progress in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3d9454f73ea5dddeab610669e0edffb"><gtr:id>d3d9454f73ea5dddeab610669e0edffb</gtr:id><gtr:otherNames>?imic G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0301-0082</gtr:issn><gtr:outcomeId>5889eb2f1e25e9.90665262</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>06CCCAB8-B123-4065-84B9-2C80CD5A4ACD</gtr:id><gtr:title>No alteration in tau exon 10 alternative splicing in tangle-bearing neurons of the Alzheimer's disease brain.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/188542496d12a1aa4bf71086006413d8"><gtr:id>188542496d12a1aa4bf71086006413d8</gtr:id><gtr:otherNames>Ingelsson M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>DF82804CB49</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A322FB2B-B193-4A5C-8367-803600F0DAC3</gtr:id><gtr:title>Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.</gtr:title><gtr:parentPublicationTitle>Neuro-degenerative diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1660-2854</gtr:issn><gtr:outcomeId>Ssds4z61AHZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B71D9B8-FC58-466A-B94F-D2FABD3BDE74</gtr:id><gtr:title>Amyotrophic lateral sclerosis with dementia: an autopsy case showing many Bunina bodies, tau-positive neuronal and astrocytic plaque-like pathologies, and pallido-nigral degeneration.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/510721e2a9e00f86705a3e2bd54d9d27"><gtr:id>510721e2a9e00f86705a3e2bd54d9d27</gtr:id><gtr:otherNames>Yokota O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>B5EB25FE480</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D111ED8-3419-4736-893B-35935DA58234</gtr:id><gtr:title>Variation in tau isoform expression in different brain regions and disease states.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a9ff70460a8a25a64715383958cc1a82"><gtr:id>a9ff70460a8a25a64715383958cc1a82</gtr:id><gtr:otherNames>Majounie E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14043_23_23428180</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>51AC7DF8-E6F6-40AB-93B3-036A425DA7F6</gtr:id><gtr:title>Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af01bcaabff4dfd4ac18896c34ef80bc"><gtr:id>af01bcaabff4dfd4ac18896c34ef80bc</gtr:id><gtr:otherNames>Lace G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>C8C4E44C75C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>513C43B6-656C-46EB-8871-33CECF9ED366</gtr:id><gtr:title>Expression of embryonic tau protein isoforms persist during adult neurogenesis in the hippocampus.</gtr:title><gtr:parentPublicationTitle>Hippocampus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cbdc6ade22e1e327ebe64087dade51fd"><gtr:id>cbdc6ade22e1e327ebe64087dade51fd</gtr:id><gtr:otherNames>Bullmann T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1050-9631</gtr:issn><gtr:outcomeId>12CC4BF5EE0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F0A71C11-99D8-4E30-B55B-7C9E6B14E44B</gtr:id><gtr:title>Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b3ab405150e2089e42f3d42e7d67f33a"><gtr:id>b3ab405150e2089e42f3d42e7d67f33a</gtr:id><gtr:otherNames>Lashley T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>A603587393B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E80F5C6-AFE9-42AF-8266-A6330AC1DCB0</gtr:id><gtr:title>The role of tau in the pathological process and clinical expression of Huntington's disease.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/634b21616124fc9c9ccca1d9429ea113"><gtr:id>634b21616124fc9c9ccca1d9429ea113</gtr:id><gtr:otherNames>Vuono R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>569507411e1679.43497465</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8A718C2-A23C-46D7-9A26-F2ED14C1C8A5</gtr:id><gtr:title>Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b20fe581f807c3e4e12bea8541550d02"><gtr:id>b20fe581f807c3e4e12bea8541550d02</gtr:id><gtr:otherNames>Luk C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>pm_14043_23_22862741</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4581D36F-B03C-41E5-82BA-CAA9ECE263B4</gtr:id><gtr:title>Aging analysis reveals slowed tau turnover and enhanced stress response in a mouse model of tauopathy.</gtr:title><gtr:parentPublicationTitle>The American journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa792daadca03e8bcc30b6c93d2b6bfc"><gtr:id>fa792daadca03e8bcc30b6c93d2b6bfc</gtr:id><gtr:otherNames>Dickey C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9440</gtr:issn><gtr:outcomeId>897C89B7AF2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6BDA8198-4AB6-447D-B1B4-FC5AB94944E4</gtr:id><gtr:title>Clinical and pathological features of an Alzheimer's disease patient with the MAPT Delta K280 mutation.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/83e57575be4e049931208ea594a82fb1"><gtr:id>83e57575be4e049931208ea594a82fb1</gtr:id><gtr:otherNames>Momeni P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>A13389FC943</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>57D28237-DC51-49FB-A556-B515CE564600</gtr:id><gtr:title>Tau gene promoter rs242557 and allele-specific protein binding</gtr:title><gtr:parentPublicationTitle>Translational Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/63e523ba065937896c65006626f34b64"><gtr:id>63e523ba065937896c65006626f34b64</gtr:id><gtr:otherNames>Anaya F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>hohrsxh582D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D93BA3F-100A-4B4E-AD72-15101AA93022</gtr:id><gtr:title>Genetic variability in the regulation of gene expression in ten regions of the human brain.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/52571622ddf586543c15906e6485b96b"><gtr:id>52571622ddf586543c15906e6485b96b</gtr:id><gtr:otherNames>Ramasamy A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>54609547a8d415.82141994</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E04EEC94-9528-4585-AF55-3DA1624DE607</gtr:id><gtr:title>The heritability and genetics of frontotemporal lobar degeneration.</gtr:title><gtr:parentPublicationTitle>Neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d7991092fd9b17c57c6e7a660ae0f34"><gtr:id>2d7991092fd9b17c57c6e7a660ae0f34</gtr:id><gtr:otherNames>Rohrer JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0028-3878</gtr:issn><gtr:outcomeId>237CF1674CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A269EA4D-86BA-418D-9CCE-EAC2787A1EEA</gtr:id><gtr:title>MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>pm_14043_23_22723018</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C3417FF-5E0A-405F-988C-7A47DD2A4436</gtr:id><gtr:title>Rational therapeutic approaches to progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d3b37a1ea4c6bb2dd69d484101a8d28c"><gtr:id>d3b37a1ea4c6bb2dd69d484101a8d28c</gtr:id><gtr:otherNames>Stamelou M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>tujD1xUeN2n</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7C68957-357C-4111-8907-871EE2FA2EEA</gtr:id><gtr:title>Genetic variation at the tau locus and clinical syndromes associated with progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Movement disorders : official journal of the Movement Disorder Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f42abd7bed2a44a080cb53f8e63b06"><gtr:id>b4f42abd7bed2a44a080cb53f8e63b06</gtr:id><gtr:otherNames>Williams DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0885-3185</gtr:issn><gtr:outcomeId>429D7945CBB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>58587B7A-F0B0-400A-A8A4-3B321A6024AB</gtr:id><gtr:title>MAPT S305I mutation: implications for argyrophilic grain disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8589a7315a7ba0fad1154b0030273cf"><gtr:id>c8589a7315a7ba0fad1154b0030273cf</gtr:id><gtr:otherNames>Kovacs GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0001-6322</gtr:issn><gtr:outcomeId>009A509DC6B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C8CBF64-E12F-4C2F-A792-1CB0C31B98C6</gtr:id><gtr:title>Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a124d1eb2194aabd08d9c85e61a281e8"><gtr:id>a124d1eb2194aabd08d9c85e61a281e8</gtr:id><gtr:otherNames>Compta Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>Wp95yHKrY74</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4CCDFD43-BC2D-4583-A98E-C362E4C247F5</gtr:id><gtr:title>Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fda6220d52d40adf421d81b63db8a2d"><gtr:id>4fda6220d52d40adf421d81b63db8a2d</gtr:id><gtr:otherNames>Suh J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>L7EkB7utpZp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24444F7F-9CF1-443D-8C97-A06979F59A13</gtr:id><gtr:title>Development of a sensitive ELISA for quantification of three- and four-repeat tau isoforms in tauopathies.</gtr:title><gtr:parentPublicationTitle>Journal of neuroscience methods</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b20fe581f807c3e4e12bea8541550d02"><gtr:id>b20fe581f807c3e4e12bea8541550d02</gtr:id><gtr:otherNames>Luk C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0165-0270</gtr:issn><gtr:outcomeId>A5E59B4EBA1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9AADD03-EF92-430D-BB96-68354515CFA5</gtr:id><gtr:title>Pick's disease with Pick bodies: an unusual autopsy case showing degeneration of the pontine nucleus, dentate nucleus, Clarke's column, and lower motor neuron.</gtr:title><gtr:parentPublicationTitle>Neuropathology : official journal of the Japanese Society of Neuropathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/892659795322a2421cb3ca295f8b6eb3"><gtr:id>892659795322a2421cb3ca295f8b6eb3</gtr:id><gtr:otherNames>Oda T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0919-6544</gtr:issn><gtr:outcomeId>9FE11D0C7ED</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>771BE780-F090-4F27-9A9D-1B8E09EF1798</gtr:id><gtr:title>Untangling the tau gene association with neurodegenerative disorders.</gtr:title><gtr:parentPublicationTitle>Human molecular genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4570f8dc50d2fdb4ca64be4322e7ad9"><gtr:id>a4570f8dc50d2fdb4ca64be4322e7ad9</gtr:id><gtr:otherNames>Pittman AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0964-6906</gtr:issn><gtr:outcomeId>77BE6B468BD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>071916C8-FC33-460F-8FD1-DFB69DAC5360</gtr:id><gtr:title>The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.</gtr:title><gtr:parentPublicationTitle>Neurobiology of disease</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2921e33324fff80be3148d6cead57b69"><gtr:id>2921e33324fff80be3148d6cead57b69</gtr:id><gtr:otherNames>Myers AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0969-9961</gtr:issn><gtr:outcomeId>E0C6ED803E1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE422AF1-907B-44BF-B49D-8264BF26B87E</gtr:id><gtr:title>Disentangling the role of the tau gene locus in sporadic tauopathies.</gtr:title><gtr:parentPublicationTitle>Current Alzheimer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737a3b1b4bbcc2863da782c70d702de5"><gtr:id>737a3b1b4bbcc2863da782c70d702de5</gtr:id><gtr:otherNames>Vandrovcova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1567-2050</gtr:issn><gtr:outcomeId>LYX1MEQn9wV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C191B8F8-026B-4161-9F85-F8584D19AAC2</gtr:id><gtr:title>Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome.</gtr:title><gtr:parentPublicationTitle>Brain : a journal of neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b4f42abd7bed2a44a080cb53f8e63b06"><gtr:id>b4f42abd7bed2a44a080cb53f8e63b06</gtr:id><gtr:otherNames>Williams DR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0006-8950</gtr:issn><gtr:outcomeId>0AFCE962B9C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F89A4D-4EA0-48D2-BE0A-474BD122215C</gtr:id><gtr:title>Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies</gtr:title><gtr:parentPublicationTitle>Current Alzheimer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/737a3b1b4bbcc2863da782c70d702de5"><gtr:id>737a3b1b4bbcc2863da782c70d702de5</gtr:id><gtr:otherNames>Vandrovcova J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_55f983983bcad54e</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DB882AB-1621-48F3-8087-AB58893E42DC</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>gzj2qQnW9Lk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36BE64CB-F6AB-4650-96DD-FF967F4FEEE0</gtr:id><gtr:title>The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Acta neuropathologica communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/08d7388ca2968e41d1c03f61e357ac69"><gtr:id>08d7388ca2968e41d1c03f61e357ac69</gtr:id><gtr:otherNames>Stutzbach LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>2051-5960</gtr:issn><gtr:outcomeId>pm_14043_23_24252572</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7058EDB7-0080-433A-92B4-3B877DAD615E</gtr:id><gtr:title>Tangle diseases and the tau haplotypes.</gtr:title><gtr:parentPublicationTitle>Alzheimer disease and associated disorders</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8cdc37128f45833332c0ee457dd6ee0e"><gtr:id>8cdc37128f45833332c0ee457dd6ee0e</gtr:id><gtr:otherNames>Hardy J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0893-0341</gtr:issn><gtr:outcomeId>58E66D24658</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABC5441F-6B27-4784-A8AD-4406FAE649B6</gtr:id><gtr:title>A cognitive chameleon: lessons from a novel MAPT mutation case.</gtr:title><gtr:parentPublicationTitle>Neurocase</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96925e58fc50223a95dd6d10f9850bc0"><gtr:id>96925e58fc50223a95dd6d10f9850bc0</gtr:id><gtr:otherNames>Liang Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1355-4794</gtr:issn><gtr:outcomeId>pm_14043_23_23998300</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DDC845BF-50C3-40DB-B3F6-1168DC6535DE</gtr:id><gtr:title>Assessment of common variability and expression quantitative trait loci for genome-wide associations for progressive supranuclear palsy.</gtr:title><gtr:parentPublicationTitle>Neurobiology of aging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b9daf1044ffaa78c220fa83b15b9c753"><gtr:id>b9daf1044ffaa78c220fa83b15b9c753</gtr:id><gtr:otherNames>Ferrari R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0197-4580</gtr:issn><gtr:outcomeId>pm_14043_23_24503276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>44D5BBBF-62D6-4492-B388-06745DB57D6E</gtr:id><gtr:title>Differential incorporation of tau isoforms in Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bc2eaabfcd616b8ed6ba828d5ad81b08"><gtr:id>bc2eaabfcd616b8ed6ba828d5ad81b08</gtr:id><gtr:otherNames>Espinoza M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>99392B90344</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501560</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>